Description

Mexia 10 (memantine) Coated Tablets 10 mg. №50

Ingredients:

Each coated tablet contains 10 mg of memantine hydrochloride as the active ingredient.

Dosage:

The recommended dosage of Mexia 10 is 10 mg taken orally once daily. Dosage may be adjusted based on individual response and tolerability.

Indications:

Mexia 10 is indicated for the treatment of moderate to severe Alzheimer’s disease. It works by regulating the activity of glutamate, a neurotransmitter involved in learning and memory.

Contraindications:

Do not use Mexia 10 if you are allergic to memantine or any other ingredients in the formulation. It is important to consult a healthcare provider before starting this medication, especially if you have a history of seizures or kidney problems.

Directions:

Swallow Mexia 10 tablets whole with water. Do not crush, chew, or break the tablets. It can be taken with or without food, as directed by a healthcare professional.

Scientific Evidence:

Studies have shown that memantine, the active ingredient in Mexia 10, can help improve cognitive function and slow the progression of Alzheimer’s disease. Research published in the Journal of Alzheimer’s Disease demonstrated the efficacy of memantine in enhancing memory and daily functioning in patients with Alzheimer’s.

Additional Information:

Mexia 10 is well-tolerated in most patients, with common side effects including dizziness, headache, and constipation. It is important to follow the prescribed dosage and consult a healthcare provider for any concerns or questions.

Memantine, the active ingredient in Mexia 10, works by blocking the excessive activity of glutamate, which can lead to neuronal damage in conditions like Alzheimer’s disease. By modulating glutamate levels, memantine helps maintain proper neurotransmission and protects brain cells from excitotoxicity.

Clinical trials have shown that Mexia 10 is effective in improving cognitive function, behavior, and overall quality of life in patients with Alzheimer’s disease. A meta-analysis published in the Journal of Clinical Pharmacology reported that memantine treatment was associated with significant improvements in cognitive scores and activities of daily living compared to a placebo.